Cardiac microdialysis to estimate interstitial adenosine and coronary blood flow.
The purpose of this study was twofold: 1) to investigate the feasibility and usefulness of cardiac microdialysis for the simultaneous estimation of regional cardiac interstitial fluid (ISF) adenosine (ADO) concentration and coronary blood flow (CBF); and 2) to determine the changes in the ISF levels of ADO and CBF during cardiac stimulation or regional myocardial ischemia. Cardiac microdialysis probes were implanted in the left ventricular myocardium of chloralose-urethan-anesthetized dogs and perfused with Krebs-Henseleit buffer. The concentration of ADO in the effluent dialysate was used as an index of intramyocardial ISF ADO concentration while local CBF was measured by H2 clearance via a platinum wire within the dialysis fiber. Dialysate ADO was elevated immediately after insertion of the microdialysis probe, declined rapidly in the first 20 min, stabilized by 60 min, and remained constant for 2 h. Based on the relationship in vitro and in vivo between microdialysis probe perfusion rate and dialysate ADO concentration, ISF ADO concentration within the left ventricular myocardium was estimated to be 0.9-1.3 microM. Dobutamine (10 micrograms.kg-1.min-1) infusion resulted in a 36% increase in CBF and a 2.5-fold increase in dialysate ADO (n = 9; P less than 0.05). Regional myocardial ischemia, induced by occlusion of the left anterior descending artery (LAD), caused a 13-fold increase in dialysate ADO in the LAD perfused myocardium (n = 9; P less than 0.05). These results are consistent with the ADO hypothesis and suggest that cardiac microdialysis provides a reliable technique for the sampling of regional intramyocardial ISF.
Van Wylen
D G
DG
Department of Surgery, School of Medicine and Biomedical Sciences, State University of New York, Buffalo 14215.
Willis
J
J
Sodhi
J
J
Weiss
R J
RJ
Lasley
R D
RD
Mentzer
R M
RM
D000241:Adenosine / Q000097:blood / Q000378:metabolism*; D000818:Animals; D003326:Coronary Circulation; D003327:Coronary Disease / Q000503:physiopathology; D003331:Coronary Vessels / Q000378:metabolism; D003956:Dialysis / Q000295:instrumentation / Q000379:methods; D004280:Dobutamine; D004285:Dogs; D004864:Equipment and Supplies; D005110:Extracellular Space / Q000378:metabolism*; D005260:Female; D006859:Hydrogen; D008297:Male; D009206:Myocardium / Q000378:metabolism*; D010477:Perfusion; D013997:Time Factors
D004280:Dobutamine; D006859:Hydrogen; D000241:Adenosine